Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 FibroGen Begins Phase 3 Trial of Pamrevlumab for IPF
2 Routine Chest Scans Advised for IPF Patients as Lung Cancer Risk...
3 Researchers Ready New Treatment for IPF
4 PDGFA Found to Stimulate Lung Tissue Repair in Aged IPF Mice
5 Preclinical Study Will Probe Potency of Cymerus MSCs
6 MYMD-1 Shows Promise in Reducing Drivers of IPF Inflammation, Fibrosis
7 Gilead, Galapagos halt IPF study in latest stumble for blockbuster alliance
8 Potential IPF Treatment, Found Using AI, May Move Into Trial...
9 Previous: Rare Disease Day Brings Me Hope as a PF Patient
10 ISABELA Phase 3 Program of Ziritaxestat for IPF to Stop, Galapagos Says
11 LUNGguard System Used for 1st Time With IPF Patient's Transplant
12 Previous: FDA Clears Potential IPF Therapy, IM156, for Phase 1 Trial
13 Stem Cell Study Into Lung Repair for IPF, Like Diseases Wins ALA Grant
14 Light at end of decade-long IPF goal if Coug fans match big gift
15 Another blow for Galapagos and Gilead as ziritaxestat fails in Phase I
16 Fitch Affirms International Personal Finance at 'BB-'; Outlook Negative
17 Insilico preps first candidate for IND studies, hoping to launch trial in IPF by end of 2021
18 Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis
19 IBSA partner IPF to promote powerlifting
20 Fitch Ratings Updates its IPF China Analytical Comparative Tool
21 USA Powerlifting Case Against IPF Moves to Court of Arbitration for Sport
22 The networks of m(6)A-SARS-CoV-2 related genes and immune infiltration patterns in idiopathic pulmonary fibrosis
23 IPF plots return to growth following 2020 loss
24 IPF: My dad died from disease Katie Price's mum is fighting
25 AdAlta (1AD): Initiation
26 Idiopathic Pulmonary Fibrosis (IPF) Market – The Courier
28 New Preclinical Study to Investigate the High Potency of Cymerus™ MSCs
29 WSU launches fundraising challenge to pay for two new athletic buildings
30 Pennsylvania county that rode the fracking wave is now broke
31 US Offshore Wind on Cusp of Tremendous Growth
32 Chinese firm Insilico to test AI-developed drug
33 Concomitant statin therapy yields benefit on IPF progression
34 Using air purification to protect against COVID-19 on campus | MSUToday | Michigan State University
35 Toward a Better Understanding of the IPF Cough
36 [Full text] The Effect of Nintedanib on T-Cell Activation, Subsets and Functions | DDDT
37 Delay from symptom onset to IPF diagnosis often longer than 1 year
38 Roche’s Actemra to rival against BI’s blockbuster drug Ofev
39 MediciNova to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
40 Earnings Update: Here's Why Analysts Just Lifted Their International Personal Finance plc (LON:IPF) Price Target To UK£1.39
41 Ofev Costs to Treat PF-ILD Should Be Reimbursed in Canada, Groups Say
42 IPF Negatively Affects Patients' Quality of Life, Review Study Finds
43 Next:Dosing Begins in 2nd Phase 3 Trial of Antibody Treatment for IPF
44 Targeted therapies developed to reduce lung fibrosis
45 Galapagos “win” highlights crowded idiopathic pulmonary fibrosis pipeline
46 Galecto Publishes GB0139 Phase 2a Idiopathic Pulmonary Fibrosis (IPF) Results in European Respiratory Journal, Showing Marked Impact on Several IPF Biomarkers
47 Calprotectin Is Potential Biomarker of IPF Severity, Study Shows
48 Fatigue Weighs on IPF Patients and Tends to Worsen Over Time...
49 New Report shows OSW renewables has potential to be next great industry
50 Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial
51 Mortality Risk Lower for IPF Patients Diagnosed More Recently...
52 Vicore Pharma Holding AB (publ) publishes the year-end report for 2020
53 Early Start: Strategies to Improve Outcomes in IPF
54 Inhalable Treatment Enhances Regeneration in Lung Fibrosis Model
55 Ofev May Be Less Tolerable Over Long Term in IPF Patients in...
56 Next:Phase 2 Trial of C21, Potential Oral Therapy for IPF, Opens
57 Idiopathic Pulmonary Fibrosis
58 Pandemic hits profits at listed lender |
59 [Full text] A Successful Defect Closure After Total Excision of Seborrheic Keratos | IMCRJ
60 Collapsed Lung Can Be Difficult to Treat in IPF, Linked to Poorer...
61 Connecticut developers pair sheep grazing with solar projects
62 Galecto raises $64m to finance EU filing for inhaled IPF drug
63 Algernon Pharmaceuticals Announces 25% Enrollment in its Ifenprodil IPF and Chronic Cough Phase 2 Human Study
64 Comprehensive Report on Plastic Valve Bags Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | Material Motion, IPF, LC Packaging – NeighborWebSJ
65 IPF Risk Genes Linked to AAV in Study, But Not to AAV-associated...
66 Oral co-trimoxazole fails to reduce adverse outcomes in patients with IPF
67 Where to find value in the commercial property sector
68 Powerlifter Josh Greiner Smashed Teen World Records In Training at 17 Years Old
69 Delayed IPF Diagnoses Linked to Heart, Gastro-esophageal Conditions
70 Massachusetts carbon tax proposed for transportation and heating
71 $2.4M NIH Grant Supports Boston Team Creating Cell Model for IPF
72 United Therapeutics Receives FDA Orphan Drug Designation For Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
73 Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress
74 Next:Treprostinil Earns FDA Orphan Drug Designation for Treating IPF
75 Powerful treatment for IPF stops dangerous scar formation in mouse lungs
76 IRONGATE GROUP – Voluntary Announcement – Acquisition of Industrial Property Acquisition
77 Algernon Announces First Patient Dosed in Phase 2 IPF and Chronic Cough Human Trial of Ifenprodil
78 Experimental Peptide Combined With Ofev Reduced IPF Symptoms in Mice
79 Next:IPF Mortality Rates Decreasing in US, New Study Concludes
80 Next:First Patient Enrolls in Study of NAC for Targeted Treatment in IPF
81 Yale, Baylor create atlas of cellular change in lungs with fibrosis
82 FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2
83 New lungs bring second chance for local senior
84 IPF market to be worth $3.6 billion by 2029, says GlobalData
85 Large Chest Lymph Nodes in IPF Patients Tied in Study to Higher...
86 FibroGen Reports Fourth Quarter and Full Year 2020 Financial Results
87 Phase 2 Trial of NP-120 for IPF Reaches 25% of Enrollment Target
88 IPF Severity, Progression Correlates With Bilirubin Levels, Study Finds
89 Katie Price pays tribute to her terminally ill mum Amy and thanks her for ‘thick skin’ on International Wom
90 Endeavor Raises $62M for New Trials for IPF Therapy Taladegib
91 Study Links IPF With Increased Risk for Several Cancer Types
92 Idiopathic pulmonary fibrosis: Definition, symptoms, and treatment
93 Algernon Begins Screening Patients for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia
94 To Succeed, I Must Share My IPF Identity With Others
95 First Patient Enrolls In PRECISIONS Study For Treatment Of Idiopathic Pulmonary Fibrosis
96 Quality of Life Reduced by IPF Respiratory, Emotional Factors, Study Says
97 CohBar Antifibrotic Peptide in Combination with Nintedanib Shows Enhanced Effects in an Idiopathic Pulmonary Fibrosis Model
98 With eyes on an IPF franchise, Galapagos pushes second candidate into a dose-finding study
99 Phase 2 Trial of Haduvio for Chronic Cough Due to IPF Again...
100 Pamrevlumab May Be More Effective in IPF Than Esbriet and Ofev...